Histoplasma capsulatum Encodes a Dipeptidyl Peptidase Active against the Mammalian Immunoregulatory Peptide, Substance P by Cooper, Kendal G. et al.
Histoplasma capsulatum Encodes a Dipeptidyl Peptidase
Active against the Mammalian Immunoregulatory
Peptide, Substance P
Kendal G. Cooper
1, Robert Zarnowski
2, Jon P. Woods
1*
1Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, United States of America, 2Department of Biology, University of
Texas-Pan American, Edinburg, Texas, United States of America
Abstract
The pathogenic fungus Histoplasma capsulatum secretes dipeptidyl peptidase (Dpp) IV enzyme activity and has two putative
DPPIV homologs (HcDPPIVA and HcDPPIVB). We previously showed that HcDPPIVB is the gene responsible for the majority of
secreted DppIV activity in H. capsulatum culture supernatant, while we could not detect any functional contribution from
HcDPPIVA. In order to determine whether HcDPPIVA encodes a functional DppIV enzyme, we expressed HcDPPIVA in Pichia
pastoris and purified the recombinant protein. The recombinant enzyme cleaved synthetic DppIV substrates and had similar
biochemical properties to other described DppIV enzymes, with temperature and pH optima of 42uC and 8, respectively.
Recombinant HcDppIVA cleaved the host immunoregulatory peptide substance P, indicating the enzyme has the potential to
affect the immune response during infection. Expression of HcDPPIVA under heterologous regulatory sequences in H.
capsulatum resulted in increased secreted DppIV activity, indicating that the encoded protein can be expressed and secreted
by its native organism. However, HcDPPIVA was not required for virulence in a murine model of histoplasmosis. This work
reports a fungal enzyme that can function to cleave the immunomodulatory host peptide substance P.
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Introduction
Histoplasma capsulatum is a thermally dimorphic fungal pathogen
of humans and other mammals. This ascomycete is found globally
in soils, often associated with bird and bat guano, and causes the
respiratory disease known as histoplasmosis [1]. Infection begins
by inhalation of microconidia or mycelial fragments small enough
to be deposited in the lung alveoli. There the mold undergoes a
morphogenic transition to the yeast form that survives and
replicates within host macrophages. H. capsulatum is capable of
infecting immunocompetent individuals, but greater morbidity
and mortality are observed when cell-mediated immunity is
compromised.
Dipeptidyl peptidase type IV (DppIV) enzymes cleave dipep-
tides from the N-terminus of proteins after a proline or less
efficiently alanine in the second position, releasing X-Pro and X-
Ala dipeptides. Human CD26 is a DppIV enzyme found in soluble
serum and cell surface membrane-bound forms that has diverse
functions including immunomodulatory effects. These effects
include alteration – usually inactivation – by enzymatic cleavage
of several chemokines such as substance P and RANTES, and
modulation of T lymphocyte proliferation via interaction with the
CD3 signaling pathway and binding of adenosine deaminase
(ADA) [2,3]. Substance P is a neuropeptide and chemokine that
affects cellular immune responses and inflammatory granuloma
formation [4,5], which are hallmarks of H. capsulatum infection and
critical for control of histoplasmosis [1].
DppIV enzymesare widely distributed among microorganisms as
well as mammals, with members present in bacteria, fungi and
protozoans. The main function of microbial DppIV enzymes is
thought to be provision of nutrition to the microorganism in the
form of dipeptides. This hypothesis is based on the observation that
DppIV- and aminopeptidase-deficient bacteria have a reduced
growth rate reversible by the addition of amino acids to the medium
[6]. However, DppIV enzymes can also contribute to virulence of
some pathogenic microorganisms such as Porphyromonas gingivalis.
This bacterium encodes a DppIV (PgDppIV) that is localized in the
bacterial outer membrane. Mice infected with a PgDppIV-null
mutant have significantly increased recruitment of inflammatory
cells to sites of infection [7]. Purified PgDppIV cleaves N-terminal
peptidesofcertainchemokinesinvitro,suggestingthat inactivationof
immunomodulatory chemokines by truncation may be responsible
forthereduced influxofinflammatorycellsin vivo [8]. PgDppIValso
contributes to host connective tissue destruction and binds
fibronectin, which may aid in colonization [9].
H. capsulatum encodes two putative DPPIV genes, HcDPPIVA and
HcDPPIVB. We previously showed that although HcDppIVA
contains a predicted signal sequence, it does not detectably
contribute to secreted DppIV activity in H. capsulatum culture
supernatants. Instead, HcDPPIVB encodes the majority of
extracellular DppIV activity under standard laboratory conditions
(Cooper et al., submitted). Here, we show that HcDPPIVA encodes
a functional DppIV enzyme that is also capable of being secreted
into H. capsulatum culture supernatant when driven under
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recombinant HcDppIVA in Pichia pastoris, biochemically charac-
terized the enzyme, and determined that it cleaves the host
immunoregulatory peptide substance P.
Methods
Strains and media
Histoplasma capsulatum strains G217Bura5-23 and DHcDPPIVA
were used for this study [10] (Cooper et al., submitted). Pichia
pastoris strain X-33 (Invitrogen, Carlsbad, CA) was used for
heterologous expression and purification of recombinant
HcDppIVA. P. pastoris transformants were selected on yeast
extract peptone dextrose medium (YPD) containing 500 mg/mL
zeocin. Buffered glycerol-complex medium (BMGY) was used to
grow P. pastoris in broth, while buffered methanol-complex
medium (BMMY) was used to induce expression of HcDPPIVA.
Escherichia coli JM109 grown in Luria-Bertani broth (LB) was used
for cloning and propagation of plasmids. H. capsulatum was
maintained in Histoplasma macrophage medium (HMM) as
previously described [11]. Plasmids were transformed by electro-
poration into H. capsulatum strains as previously described [11].
Fungal supernatant preparation
H. capsulatum culture supernatants were harvested by pelleting
cells at 12006g for 10 min at 24uC. Supernatants were filtered
with 0.22 mm PES membranes and concentrated 15–306 using
regenerated cellulose filter devices with a molecular cut-off weight
of 5 kDa (Millipore, Bedford, MA). Total protein concentration
was determined using the Bradford assay (Bio-Rad, Hercules, CA).
Microtiter plate DppIV enzymatic assay
90 ml of each supernatant was added to 96 well plates. 10 mlo f
Gly-pro-7-amido-4-methylcoumarin hydrobromide (Gly-pro-
AMC) was added for a final concentration of 200 mM (Sigma,
St. Louis, MO). Samples were incubated at 37uC with shaking.
Enzymatic cleavage leading to the release of the fluorescent AMC
molecule was measured using a microplate spectrofluorometer
(SPECTRAmax Gemini EM, Molecular Devices) with excitation
and emission wavelengths of 360 and 440 nm, respectively.
In-gel zymogram DppIV enzymatic assay
Equal amounts of supernatant protein were separated on 6%
native PAGE gels containing no SDS. After electrophoresis, gels
were overlaid with 0.3% agarose in 50 mM Tris pH 8 containing
400 mM Gly-pro-AMC and incubated at 37uC for 20 minutes.
Bands of fluorescence were visualized using a Gel Doc 1000
documentation system (Bio-Rad). Gels were subsequently stained
with Coomassie Brilliant Blue to visual total protein.
Northern hybridization
RNA was collected from late log phase cultures of G217B using
RiboPure kit (Ambion) following manufacturer’s instructions. 23–
28 mg RNA was electrophoresed in a 1% formaldehyde agarose gel
and then transferred to Hybond N+ nylon transfer membrane
(Amersham). The blot was probed with a labeled plasmid containing
HcDPPIVA. The blot was then stripped by boiling in 0.5% SDS and
re-probed with a labeled plasmid containing 590 bp of H. capsulatum
ACT1 cDNA for normalization with the actin gene transcript.
Preparation of H. capsulatum cDNA
RNA was collected from log phase cultures of G217B using
TRIzol Reagent (Invitrogen) following manufacturer’s instructions.
ContaminatingDNA was removed by treatment with Amplification
grade DNase I (Invitrogen). Reverse transcription reactions were
carried out using SuperScript First-Strand Synthesis System
(Invitrogen) following the manufacturer’s protocol.
Polymerase chain reaction
PCR amplification was performed using the TripleMaster high
fidelity PCR system (Eppendorf, Westbury, NY) following the
manufacturer’s instructions. All primers were designed from
sequences obtained from the Histoplasma capsulatum G217B
genomic database (www.genome.wustl.edu) using MacVector
sequence analysis software (Accelrys). Primers were synthesized
by Integrated DNA Technologies (IDT, Coralville, IA).
Overexpression of HcDPPIVA in H. capsulatum
We used an H. capsulatum expression vector pLBZ-1 described
previously [12]. It carries a PaURA5 marker for selection, an inverted
telomeric region for linearization and maintenance, and cloning sites
between the H2B 59and CATB 39flanking sequences.To overexpress
HcDPPIVA in H. capsulatum,t h eHcDPPIVA full-length ORF was
amplified from cDNA with primers (o-1) 59-NNNggcgcgccAT-
GAAGGCATTTTCTCTT-39 and (o-2) 59-NNNNNNcctgcaggt-
tattacagatcttcttcagaaatcagtttttgttcAAATCTCAGGCCATTCCGA-
TCC-39 and cloned into pLBZ-1 using the AscIa n dSbfI sites (shown
in bold type). A C-terminal c-myc tag was incorporated (underline);
this tag was incidental for H. capsulatum expression in this study, but
was used in P. pastoris expression as described below. The resulting
plasmid was named pDPP-OE. Both pLBZ-1 (empty vector) and
pDPP-OE were transformed into G217Bura5-23. Transformants
were selected for uracil protrophy.
Expression and purification of HcDppIVA in Pichia
pastoris
Expression of HcDPPIVA in Pichia pastoris was performed using
the EasySelect Pichia Expression Kit (Invitrogen). The HcDPPIVA
ORF was amplified from cDNA with primers (p-1) 59-NNN-
NNNcacgtgATGAAGGCATTTTCTCT-39 and (p-2) 59-NNN-
NNNgcggccgctcatcaatggtgatggtgatggtgAAATCTCAGGCCATT-
CCGATCC-39 and cloned into pPICZA using the PmlI and NotI
sites (shown in bold type). A carboxyl-terminal 66His tag was also
included (shown in underline). The resulting plasmid was named
pDPP-PIC. P. pastoris was transformed according to the manufac-
turer’s instructions. Pichia transformants were selected on 500 mg/
mL zeocin. Methanol induction of expression was carried out
according to manufacturer’s instructions. We were unable to
purify the recombinant protein using nickel affinity chromatogra-
phy. Instead, HcDppIVA was purified from Pichia culture
supernatant by the following protocol. Pichia culture supernatant
was stirred with 1/10 vol of a 1 M Tris-HCl, pH 8.0 buffer and
subjected to ammonium sulfate precipitation. Ballast proteins were
precipitated from the solution at 30% saturation for 1 h at RT.
The mixture was then centrifuged at 35006g for 15 minutes and
the collected supernatant was concentrated using a Vivaflow 200
unit (Sartorius AG, Goettingen, Germany) equipped with a
hydrosart 10-kDa cut-off membrane. The resulting protein sample
was subjected to column chromatography purification. All
chromatographic separation steps were performed at room
temperature on the high-performance liquid chromatography
A ¨KTA-Purifier 10 system (Amersham Biosciences AB, Uppsala,
Sweden). All buffers used were filtered through 0.2 mm nylon
membrane filters (Nalgene, Rochester, NY). The elution of
proteins was monitored at a UV absorbance of 280 nm. Protein
amounts were assessed using the BCA Protein Assay Kit (Pierce
H. capsulatum DppIVA
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standard. The protein sample was chromatographically desalted on a
5-ml HiTrap
TM Desalting column (Amersham) and then separated
on an anion exchanger HiPrep
TM 16/10 DEAE FF column
(Amersham) equilibrated with 20 mM Tris/HCl (pH 8.0). Elution
was carried out in 20 mM Tris/HCl (pH 8.0) amended with 1 M
NaCl.Proteinswereelutedinalinearsaltgradientfrom0to70%in7
column volumes. DppIV active fractions eluted from the column at a
conductivity range of 11–21 mS/cm were pooled together and
concentrated using Vivaspin 20 units equipped with polyethersulfone
5-kDa nominal molecular mass cutoff limit membranes (Sartorius).
The protein sample was then applied to gel filtration on a
HighPrep
TM 16/60 Sephacryl
TM S-200 HR column (Amersham)
equilibrated with PBS. Proteins were eluted at a flow rate of 1 ml/
min in 1.5column volume. Fractions containing DppIV activity were
collected, concentrated and desalted on the HiTrap
TM Desalting
column, and subsequently separated in anion exchange chromatog-
raphy on a MonoQ
TM 5/50 GL column (Amersham) equilibrated
with 20 mM bis-Tris/HCl (pH 6.5). Proteins were eluted in 10
column volumes in a linear salt gradient to 0.25 M NaCl. DppIV
positive fractions were eluted at a conductivity range between 17 and
32 mS/cm. The final purification step involved gel filtration
chromatography on a Superdex
TM 200 10/300 GL column
(Amersham) equilibrated with PBS. HcDppIVA was eluted in 1.5
column volumes in this buffer at a flow rate of 0.5 ml/min. Specific
activity of the purified enzyme was calculated by enzyme assay using
Gly-pro-AMC with reference to a standard curve determined using
porcine kidney DppIV (Sigma).
Determination of pH and temperature optima and effect
on enzyme stability
To determine the pH optimum of recombinant HcDppIVA,
enzyme assays using purified HcDppIVA with Gly-pro-AMC were
performed in the following buffers: formate (pH 3), acetate (pH 4),
piperazine (pH 5), MES (pH 6), PIPES (pH 7), HEPES (pH 8),
and tricine (pH 9). Temperature optimum assays were performed
in HEPES (pH 8) buffer at 4, 12, 25, 37, 42, 50 and 65uC.
Stability was assessed by pre-incubating enzyme at each pH or
temperature for 30 minutes and then performing an enzyme assay
at pH 8 and 37uC to measure remaining activity. The incubation
time for all enzyme assays was one hour.
Truncation of substance P by HcDppIVA
5 mU recombinant HcDppIVA or 100 ng murine CD26 (R&D
Systems) was incubated with 50 mg substance P (Sigma) in 50 mM
Tris pH 8 at 37uC overnight. Reactions were then resuspended in
0.1% trifluoroacetic acid in 30% acetonitrile and separated using a
Superdex Peptide 10/300 GL column (Amersham).
Infection of mice with H. capsulatum
5–6 week-old female C57BL/6 mice (Harlan Laboratories,
Madison WI) were inoculated intranasally with approximately
2610
6 yeast cells in a 20-ml volume. After one week, mice were
euthanized by CO2 inhalation and lungs, livers, and spleens were
harvested to evaluate CFU. Organs were placed in sterile distilled
water and homogenized using a Stomacher 80 Biomaster (Seward,
London UK). Homogenates were plated on Brain Heart Infusion
agar plates and incubated at 22–24uC for 2–4 weeks.
Results
Purification and biochemical characterization of
recombinant HcDppIVA
In order to test whether HcDPPIVA encoding a putative DppIV
enzyme was functional, we expressed the HcDPPIVA open reading
frame with its native signal sequence and a C-terminal histidine
tag in the methylotrophic yeast Pichia pastoris. After transformation,
we induced expression of HcDPPIVA by the addition of methanol
to the medium. Culture supernatants were harvested and enzyme
activity was detected using a zymogram assay. A fluorescent band
appeared in HcDPPIVA-expressing Pichia supernatant but not a
control strain transformed with empty vector, suggesting that
HcDPPIVA encodes an active DppIV enzyme with a functional
secretion signal (Figure 1A). The apparent molecular weight of the
recombinant protein was larger than the predicted molecular
weight of 88 kilodaltons, suggesting that the enzyme is assembled
Figure 1. Expression and purification of recombinant HcDppIVA in Pichia pastoris. (A) Gly-pro-AMC zymogram of supernatants from P.
pastoris transformed with empty vector and HcDppIVA-expressing Pichia (mcr#1). Molecular weights (kDa) are indicated on the right. (B) SDS-PAGE
gel of supernatants from a non-expressing strain (vector) and mcr#1 as well as the purified fraction of HcDppIVA (rDppIV). The arrow indicates the
band likely corresponding to the enzyme. The molecular weight markers (MWM) are in the first lane of the gel. The gel was stained with Coomassie
Brilliant Blue.
doi:10.1371/journal.pone.0005281.g001
H. capsulatum DppIVA
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experimentally determined the basis for the size or whether
multimerization or modification is necessary for function.
Dimerization and/or glycosylation have been described for other
DppIV enzymes, including Porphyromonas gingivalis DppIV [8] and
human CD26 [13,14]. To characterize the biochemical properties
of HcDppIVA, we attempted to purify the C-terminal histidine-
tagged enzyme using Ni
2+ chromatography but were unsuccessful.
Instead, we performed analytical-scale purification of recombinant
enzyme from Pichia pastoris culture supernatant using anion
exchange and size exclusion chromatography (Figure 1B). We
measured DppIV activity of the purified preparation towards Gly-
pro-AMC in different buffers and temperatures to determine
optimal enzymatic conditions and stability of the enzyme. Similar
to reported values for other DppIV enzymes, HcDppIVA is
optimally active at 42uC and pH 8. Additionally, HcDppIVA is
destabilized by low pH or high temperature (Figure 2). These data
indicate that HcDPPIVA encodes a DppIV-type enzyme with
biochemical properties similar to those previously reported for
DppIV enzymes. As further demonstration of recombinant H.
capsulatum enzyme expression in P. pastoris, we replaced the
carboxyl-terminal his-tag with a c-myc epitope tag followed by
transformation, expression, and supernatant isolation as described
above. Western immunoblotting with anti-c-myc antibody re-
vealed a reactive band from P. pastoris transformed with the
expression plasmid but not empty vector (data not shown).
Furthermore, immunoprecipitation of this recombinant P. pastoris
supernatant with anti-c-myc antibody yielded DppIV activity (data
not shown).
HcDppIVA can cleave a host immunoregulatory peptide
To determine whether HcDppIVA can cleave the host
immunoregulatory peptide substance P, we incubated
rHcDppIVA or CD26 with 50 mg substance P in 50 mM Tris
pH 8 at 37u. Reactions were then resuspended in 0.1%
trifluoroacetic acid in 30% acetonitrile and separated using a
Superdex Peptide 10/300 GL column. We observed a single peak
with retention volume of 12.8 mL when substance P was
incubated without enzyme. After incubation with rHcDppIVA
or CD26, two peaks were detected with retention volumes of
14.3 mL and 17 mL indicating that substance P was cleaved
(Figure 3). CD26 cleaves substance P after the proline in the
second position from the amino-terminus, releasing Arg-Pro and
then subsequently cleaves again releasing Lys-Pro [15,16]. We
have not identified the substance P products after HcDppIVA or
CD26 mediated cleavage in this study, but it is likely that the first
peak represents the product of the first cleavage event (SP 3-11),
while the second is the product after removal of all four amino
acids (SP 5-11). The similar elution profiles after incubation with
both enzymes indicates that HcDppIVA can cleave substance P in
the same manner as CD26.
Overexpression of HcDPPIVA in H. capsulatum
In order to manipulate expression of HcDPPIVA in its native
organism, we overexpressed it in H. capsulatum strain G217Bura5-
23 by placing the open reading frame under the control of the
heterologous H2B promoter and CATB terminator sequences on a
Figure 2. Activity and stability of purified recombinant HcDppIVA. A range of temperature (A) and pH (B) conditions were examined using
substrate Gly-pro-AMC. To determine activity at different temperatures and pH, enzyme activity assays were performed at the indicated temperatures
or pH values (squares). To determine stability, purified enzyme was incubated at the indicated condition for 30 minutes and subsequently assayed for
remaining activity at pH 7, 37uC (triangles). The values in conditions with the highest activity were set at 100%. Error bars represent the variability
between two experiments.
doi:10.1371/journal.pone.0005281.g002
Figure 3. Chromatogram showing substance P truncation by
HcDppIVA. 50 mg substance P was incubated with or without 5 mU
recombinant HcDppIVA. Solid line: undigested substance P; heavy
dotted line: substance P + HcDppIVA, light dotted line: purified
HcDppIVA alone. Elution volumes for truncated substance P products
correspond to those of CD26-mediated truncation (data not shown).
doi:10.1371/journal.pone.0005281.g003
H. capsulatum DppIVA
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transcript levels (figure 4B) and secreted DppIV activity in culture
supernatants when H. capsulatum was transformed with this
HcDPPIVA expression construct. This activity increase was
monitored quantitatively by enzyme assay (figure 4A) and
qualitatively by zymography (figure 4C). These data indicate that
lack of expression from native HcDPPIVA regulatory sequences is
responsible for the previously reported lack of detectable secreted
activity under standard laboratory conditions (Cooper et al.,
submitted). When expression of this gene is increased using
heterologous regulatory sequences, HcDppIVA is produced and
secreted into culture supernatants.
Evaluation of an HcDPPIVA-null mutant in virulence
We previously constructed an HcDPPIVA-deletion mutant using
a Ku-deficient strain of H. capsulatum. Consistent with the present
study, no detectable differences were observed in secreted activity
due to loss of the gene, further indicating a lack of expression
under these conditions (Cooper et al., submitted). However, it is
possible that HcDPPIVA expression is induced during infection. In
order to determine whether HcDPPIVA is important for patho-
genesis, we used a mouse model of histoplasmosis as previously
described [17]. We did not observe a virulence defect due to
HcDPPIVA deficiency relative to the parental DKU70/KU80 strain
based on measurement of fungal burden in lungs, liver, and spleen
one week after intranasal infection (data not shown). We cannot
exclude an HcDPPIVA deficiency-associated virulence defect that
might be detected in survival, histopathology, or other in vivo or in
vitro infection models.
Discussion
The opportunistic fungal pathogen Aspergillus fumigatus secretes a
DppIV enzyme that has been postulated as a virulence
determinant [18]. This assessment is partly based on the
observation that AfDppIV cleaves host immunoregulatory pep-
tides in vitro [19]. Additionally, pre-treatment of rabbits with
recombinant AfDppIV reduces inflammation caused by histamine,
possibly by the inactivation of neuropeptides and other immuno-
modulatory peptides [20]. The closest homolog to A. fumigatus
DPPIV in H. capsulatum is HcDPPIVA. HcDPPIVA encodes a
putative DppIV enzyme that contains a predicted secretion signal.
However our previous study showed that under standard in vitro
culture conditions HcDPPIVA did not detectably contribute to
secreted DppIV activity in H. capsulatum culture supernatant
(Cooper et al., submitted). This study provides evidence indicating
that HcDPPIVA encodes an active DppIV enzyme that is capable
of being secreted. First, HcDppIVA contains an N-terminal signal
sequence that functions properly in Pichia pastoris for secretion of
the protein into the culture supernatant. Second, overexpression of
HcDPPIVA in H. capsulatum leads to increases in the level of DppIV
activity in the culture supernatant. Together, these data indicate
that HcDPPIVA encodes a fully functional DppIV enzyme capable
of being secreted by H. capsulatum.
Although under standard laboratory conditions HcDPPIVA does
not appear to contribute to the secreted DppIV activity, it is
possible that this gene is expressed only during a specific growth
condition such as during infection. It is not unusual for members of
a single protease family to be differentially expressed, as
demonstrated in a number of fungal systems. In H. capsulatum,
different serine protease activities are produced at different culture
growth stages [21]. Another example is the SAP family of C.
albicans protease genes with 10 currently identified members.
Under standard laboratory conditions, Sap2 is the major protease
to be expressed [22]. However the other SAPs are upregulated in a
wide variety of conditions such as during yeast to hyphal
transition, biofilm formation, phenotypic switching, or while
infecting a host (for review see [23]). Secreted dipeptidyl and
tripeptidyl petidase homologs are upregulated during infection by
dermatophyte fungi of the genus Trichophyton [24] and the
dimorphic fungal entomopathogen Beauveria bassiana [25].
We initially hypothesized that HcDppIVA influences infection by
cleaving and thereby altering the activity of host immunomodulatory
chemokines such as substance P, a mechanism demonstrated for
Poryphyromonas gingivalis [7,8] and postulated for Aspergillus fumigatus
[18–20]. Our results indicate that HcDPPIVA is not required for
virulence of H. capsulatum in a mouse model of histoplasmosis assessed
by fungal CFU burden in infected tissues. However, an effect of
Figure 4. Overexpression of HcDPPIVA in Histoplasma capsulatum. (A) DppIV activity using substrate Gly-pro-AMC in supernatants of
G217Bura5-23 strains carrying the empty vector pLBZ-1 (v-2, v-5) and strains carrying the pDPP-OE overexpression plasmid (OE-4, OE-5, OE-6). (B)
Northern analysis using HcDPPIVA or ACT1 specific hybridization probes. (C) Gly-pro-AMC zymogram using supernatants of indicated strains.
doi:10.1371/journal.pone.0005281.g004
H. capsulatum DppIVA
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capsulatum-induced granulomas or measurement of chemokine
activity. Furthermore, because HcDPPIVB also can provide secreted
DppIV activity, it is possible this gene contributes during infection
and may compensate in the absence of HcDPPIVA.
Because both HcDppIVA and HcDppIVB are capable of being
secreted and at least one can cleave the host immunoregulatory
peptide substance P, a further investigation into DppIV enzymes
as potential virulence factors of H. capsulatum is warranted.
Substance P is a neuropeptide that also has an important role in
immune regulation, one of which is to upregulate interferon-
gamma production [26]. This peptide binds its receptor NK-1
with high affinity and elicits a pro-inflammatory response. N-
terminal truncation of substance P destabilizes the peptide leading
to its rapid degradation by aminopeptidase M [15,16]. Addition-
ally, the N-terminal prolines in substance P prevent binding to the
other tachykinin receptors NK-2 and NK-3 [27]. Removal of
these prolines presumably could lead to loss of NK-1 specificity,
and therefore shift the relative binding to include NK-2 and NK-3.
Pro-inflammatory signaling mediated by substance P acts through
NK-1 [28–30], indicating that a shift away from NK-1 receptor
engagement may reduce overall inflammation. Other potential
host DppIV substrates with a role in inflammation include such
peptides as neuropeptide Y and vasoactive intestinal peptide
[31,32] as well as chemokines such as RANTES and eotaxin
[33,34]. Further experiments are planned to test substrate
specificity and relative activity of H. capsulatum DppIV enzymes
in comparison to those of CD26 and to determine possible
physiological effect during infection.
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